Cargando…

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy

Preoperative neoadjuvant chemoradiotherapy (nCRT) is the gold standard in locally advanced rectal cancer, only 10–30% of patients achieving benefits. Currently, there is a need of a reliable selection of markers for the identification of poor or non-responders prior to therapy. In this work, we comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Repetto, Ombretta, De Re, Valli, De Paoli, Antonino, Belluco, Claudio, Alessandrini, Lara, Canzonieri, Vincenzo, Cannizzaro, Renato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438653/ https://www.ncbi.nlm.nih.gov/pubmed/28423701 http://dx.doi.org/10.18632/oncotarget.16053

Ejemplares similares

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020)

Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response
por: Belluco, Claudio, et al.
Publicado: (2016)

Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
por: De Re, Valli, et al.
Publicado: (2017)

Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas
por: Spessotto, Paola, et al.
Publicado: (2017)

A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area
por: De Re, Valli, et al.
Publicado: (2023)

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
por: Dalle Fratte, Chiara, et al.
Publicado: (2022)

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
por: Dreussi, Eva, et al.
Publicado: (2016)

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies
por: Belluco, Claudio, et al.
Publicado: (2011)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
por: Dreussi, Eva, et al.
Publicado: (2016)

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2021)

Proposed Molecular and miRNA Classification of Gastric Cancer
por: Alessandrini, Lara, et al.
Publicado: (2018)

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2019)

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017)

Endomicroscopy and Cancer: A New Approach to the Visualization of Neoangiogenesis
por: Cannizzaro, Renato, et al.
Publicado: (2012)

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2018)

Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer
por: Repetto, Ombretta, et al.
Publicado: (2021)

Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: D’Alimonte, Lucrezia, et al.
Publicado: (2020)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Two-dimensional gel proteome reference map of human small intestine
por: Simula, Maria Paola, et al.
Publicado: (2009)

Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis
por: Fornasarig, Mara, et al.
Publicado: (2018)

Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report
por: Clemente, Nicolò, et al.
Publicado: (2017)

HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
por: De Re, Valli, et al.
Publicado: (2022)

pCLE detects mucosal neoplastic vascular pattern in gastric linitis plastica
por: Fornasarig, Mara, et al.
Publicado: (2022)

Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer
por: Garziera, Marica, et al.
Publicado: (2013)

Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer
por: Basile, Debora, et al.
Publicado: (2019)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)

Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy
por: Bádon, Emese Sarolta, et al.
Publicado: (2023)

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype
por: Caggiari, Laura, et al.
Publicado: (2017)

Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
por: Sirohi, Bhawna, et al.
Publicado: (2014)

MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
por: De Re, Valli, et al.
Publicado: (2009)

Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy
por: Foti, Pietro Valerio, et al.
Publicado: (2016)

Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2022)

Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
por: Dolcetti, Riccardo, et al.
Publicado: (2018)

New Insights into the Pathogenesis of Celiac Disease
por: De Re, Valli, et al.
Publicado: (2017)

Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
por: Alvarado-Miranda, Alberto, et al.
Publicado: (2009)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tf6ns3crsmsfnj5tfmfukjo6po